Indication

SARS coronavirus

1 clinical trial

2 products

Clinical trial

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Status: Completed, Estimated PCD: 2022-09-05

Product

Product